Literature DB >> 6472198

The distribution and effect of Chlamydia trachomatis in CBA mice inoculated genitally, intra-articularly or intravenously.

M Tuffrey, P Falder, B Thomas, D Taylor-Robinson.   

Abstract

A "fast" egg-killing human strain of Chlamydia trachomatis was inoculated into normal CBA and congenic CBA/nu mice, which have an impairment of T-cell function and do not produce anti-chlamydial antibodies. The mice were inoculated by the intra-uterine, intra-articular, or intravenous routes. Some of the mice were first treated with progesterone, which allows successful chlamydial infection of the mouse genital tract when the organisms are introduced genitally. Mice were sacrificed up to 27 days after inoculation. Homogenates of joints, genital tract, spleen, liver, kidneys, eyes and lungs were prepared and tested for chlamydiae in cycloheximide-treated McCoy cell cultures. Chlamydiae were detected in the genital tracts and spleens, but not in the joints, of mice inoculated via the intra-uterine route. They were found in the joints and spleens of mice inoculated intra-articularly, and were detected also in spleens and, from the 4th to 6th day after inoculation, in joints of mice given the organisms intravenously. These results were obtained irrespective of whether or not the mice had received progesterone. The numbers of chlamydiae in the spleens and joints of the nude mice were larger and they persisted longer than in the corresponding immunocompetent animals, although this was not true for chlamydiae in the genital tract of mice inoculated via the intra-uterine route. Compartmentalisation of chlamydiae was evident although the spleen was infected consistently irrespective of the route of inoculation and, as mentioned, chlamydiae were found transiently in the joints following intravenous inoculation. This suggests that chlamydiae might also enter the human joint.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6472198     DOI: 10.1007/bf02123566

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  5 in total

1.  Simplified serological test for antibodies to Chlamydia trachomatis.

Authors:  B J Thomas; P Reeve; J D Oriel
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

Review 2.  Chlamydial infection in the aetiology of arthritis.

Authors:  A Keat; B J Thomas; D Taylor-Robinson
Journal:  Br Med Bull       Date:  1983-04       Impact factor: 4.291

3.  Early detection of chlamydial inclusions combining the use of cycloheximide-treated McCoy cells and immunofluorescence staining.

Authors:  B J Thomas; R T Evans; G R Hutchinson; D Taylor-Robinson
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

4.  Effect of inherited deficiency of the fifth component of complement on arthritis induced in mice by Mycoplasma pulmonis.

Authors:  E Keystone; D Taylor-Robinson; C Pope; G Taylor; P Furr
Journal:  Arthritis Rheum       Date:  1978 Sep-Oct

5.  Genital-tract infection and disease in nude and immunologically competent mice after inoculation of a human strain of Chlamydia trachomatis.

Authors:  M Tuffrey; P Falder; D Taylor-Robinson
Journal:  Br J Exp Pathol       Date:  1982-10
  5 in total
  4 in total

1.  Induction of arthritis in C57B1/6 mice by chlamydial antigen. Effect of prior immunization or infection.

Authors:  A J Hough; R G Rank
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

2.  Immune responses of mice after conjunctival exposure to Chlamydia trachomatis serovar A.

Authors:  I S Barsoum; L K Hardin; D G Colley
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

3.  Pathogenesis of acute arthritis due to viable Chlamydia trachomatis (mouse pneumonitis agent) in C57Bl/6 mice.

Authors:  A J Hough; R G Rank
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

4.  Ocular sensitization of mice by live (but not irradiated) Chlamydia trachomatis serovar A.

Authors:  D G Colley; T G Goodman; I S Barsoum
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.